GLP-1 agonists for weight loss: What you need to know Evidence suggests substantial beneficial effects on weight and glycemic dysregulation

Joseph F. Goldberg

doi:10.12788/cp.0318

GLP-1 agonists for weight loss: What you need to know Evidence suggests substantial beneficial effects on weight and glycemic dysregulation

Joseph F. Goldberg

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	21-27
Number of pages	7
Journal	Current Psychiatry
Volume	22
Issue number	1
DOIs	https://doi.org/10.12788/cp.0318
State	Published - Jan 2023

Access to Document

10.12788/cp.0318

Cite this

@article{88758112f7fe42a1940187fa9e487297,

title = "GLP-1 agonists for weight loss: What you need to know Evidence suggests substantial beneficial effects on weight and glycemic dysregulation",

author = "Goldberg, \{Joseph F.\}",

year = "2023",

month = jan,

doi = "10.12788/cp.0318",

language = "English",

volume = "22",

pages = "21--27",

journal = "Current Psychiatry",

issn = "1537-8276",

publisher = "Frontline Medical Communications Inc.",

number = "1",

}

TY - JOUR

T1 - GLP-1 agonists for weight loss

T2 - What you need to know Evidence suggests substantial beneficial effects on weight and glycemic dysregulation

AU - Goldberg, Joseph F.

PY - 2023/1

Y1 - 2023/1

UR - https://www.scopus.com/pages/publications/85166149484

U2 - 10.12788/cp.0318

DO - 10.12788/cp.0318

M3 - Article

AN - SCOPUS:85166149484

SN - 1537-8276

VL - 22

SP - 21

EP - 27

JO - Current Psychiatry

JF - Current Psychiatry

IS - 1

ER -